ELDN Nov 2024 5.000 put

OPR - OPR Delayed Price. Currency in USD

0.6200

0.0000

(0.00%)

As of 11:52AM EST. Market open.

Simply Wall St.
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions
Key Insights Eledon Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...
GlobeNewswire
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive initial data from first three subjects with type 1 diabetes treated with tegoprubart as part of immunosuppression regimen following islet transplantation in investigator-initiated trial at UChicago Medicine Announced oversubscribed $85 million underwritten offering, with proceeds expected to extend cas